As shown in Figure 1J, the relapse cells (ALL‐190R), which harbored PRPS1 S103R mutation, were more sensitive to 5‐FU action than diagnosis samples (ALL‐190D). The gene discussed is PRPS1; the disease is acute lymphoblastic leukemia.